Search Results
Jul 04, 2025, 22:53 ET HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities between April 29, 2025 and June
More news about: Kahn Swick & Foti, LLC
Jul 04, 2025, 05:25 ET INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' top executives with violations
More news about: Robbins Geller Rudman & Dowd LLP
Jul 03, 2025, 12:31 ET Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). IF
More news about: Law Offices of Howard G. Smith
Jul 03, 2025, 09:00 ET Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact The Gross Law Firm
July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
More news about: The Gross Law Firm
Jul 03, 2025, 08:30 ET SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff
More news about: Faruqi & Faruqi, LLP
Jul 02, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jul 01, 2025, 15:41 ET Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS)
litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025
More news about: Berger Montague
Jul 01, 2025, 14:50 ET HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
disclose that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ("Novo") would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products
More news about: THE ROSEN LAW FIRM, P. A.
Jul 01, 2025, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS
July 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Jun 30, 2025, 16:15 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations
More news about: The Schall Law Firm
Jun 30, 2025, 16:00 ET HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
More news about: Bronstein, Gewirtz & Grossman, LLC
Jun 30, 2025, 14:15 ET HIMS Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed
California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of those who purchased
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 30, 2025, 07:15 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' top executives with violations
More news about: Robbins Geller Rudman & Dowd LLP
Jun 27, 2025, 22:41 ET HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities between April 29, 2025 and June
More news about: ClaimsFiler
Jun 27, 2025, 15:46 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jun 27, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jun 27, 2025, 09:01 ET Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman
securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company's executives. Sookdeo v. Hims & Hers Health, Inc., et al., No. 3:25-cv-05315 (N.D. Cal.) and Yaghsizian v. Hims & Hers Health, Inc. et al., No. 3:25-cv-05321
More news about: Hagens Berman Sobol Shapiro LLP
Jun 27, 2025, 06:42 ET Weekly Recap: 12 Health Press Releases You Need to See
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing In support of transitioning patients from
More news about: PR Newswire
Jun 27, 2025, 06:02 ET 12 Press Releases You Need to See This Week
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing"Novo Nordisk is firm on our position
More news about: PR Newswire
Jun 26, 2025, 18:29 ET Faruqi & Faruqi Reminds Hims & Hers Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff
More news about: Faruqi & Faruqi, LLP
Jun 26, 2025, 17:43 ET HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers' top executives with violations
More news about: Robbins Geller Rudman & Dowd LLP
Jun 26, 2025, 13:54 ET HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
disclose that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ("Novo") would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products
More news about: THE ROSEN LAW FIRM, P. A.
Jun 25, 2025, 14:08 ET Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman
844-916-0895 Hims & Hers Health, Inc. (HIMS) Investigation: In the past, Hims & Hers has assured investors of its regulatory compliance, stating "[w]e are not bypassing the regulatory process[.]" On April 29, 2025, the price of Hims & Hers shares
More news about: Hagens Berman Sobol Shapiro LLP
Jun 24, 2025, 17:42 ET Berger Montague Investigates Potential Securities Class Action Against Hims & Hers Health, Inc.
firm, is investigating potential claims on behalf of investors who purchased or otherwise acquired securities of Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).
More news about: Berger Montague
Jun 23, 2025, 23:55 ET Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations
More news about: DJS Law Group LLP